In 2021, hair dyes accounted for the largest amount of the hair remedies production in Japan with approximately 152.4 billion Japanese yen of production value. Compared to that, permanent wave agents containing cysteine accounted for the smallest production value of only 792 million yen.
Production value of hair remedies in Japan in 2021, by item (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$149 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Hair remedies production quantity in Japan 2016, by item
- Premium Statistic Biopharmaceuticals market value in Latin America 2022-2027
- Premium Statistic Antibodies market value in Latin America 2022-2027
- Basic Statistic Gross profit of Sobi 2009-2022
- Basic Statistic Annual profit/loss of Sobi 2009-2022
- Basic Statistic Number of employees at Sobi 2013-2022
- Basic Statistic Annual revenue of Sobi 2009-2022
- Basic Statistic Import share of pharmaceuticals to Sweden 2022, by country
- Basic Statistic Export share of pharmaceuticals from Sweden 2022, by country
- Premium Statistic Value of monthly imports of medical and pharmaceutical products Australia 2020-2023
About the region
10
- Premium Statistic Medicated cosmetics production quantity in Japan 2016, by item
- Premium Statistic Quasi drugs production value in Japan 2012-2021
- Premium Statistic Quasi drugs production value in Japan 2021, by therapeutic category
- Premium Statistic Breakdown of quasi-drugs production in Japan 2021, by therapeutic category
- Premium Statistic Biosimilar market size Japan 2018-2030
- Premium Statistic Biopharmaceutical market size forecast Japan 2011-2020
- Premium Statistic Number of prescription drugs approved by PMDA Japan FY 2015-2022, by type
- Premium Statistic Number of BTC and OTC drugs approved by PMDA Japan FY 2013-2022
- Premium Statistic Number of in vitro diagnostics approved by PMDA Japan FY 2013-2022
- Premium Statistic Number of quasi-drugs approved by PMDA Japan FY 2013-2022
Selected statistics
10
- Basic Statistic Sanofi's total assets 2007-2022
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2022
- Basic Statistic Merck & Co cash dividends declared 2006-2022
- Premium Statistic Merck & Co - expenditure on research and development 2006-2022
- Basic Statistic Merck & Co total assets 2009-2022
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2022
- Premium Statistic Johnson & Johnson's number of employees 2004-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2022 by region
- Basic Statistic GSK's operating profit by division 2006-2021
Other regions
10
- Premium Statistic Market value of prescription drugs in Italy 2001-2022
- Premium Statistic Pharmaceutical sales value in Mexico 2021, by segment
- Basic Statistic Number of applications for drug reimbursement in Denmark 2013-2022
- Premium Statistic Leading orphan designations in the EU by indication 2015
- Basic Statistic Oregon's medical cannabis sales value U.S. 2018-2024
- Basic Statistic Nevada's medical cannabis spending 2018-2024
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Maine's medical cannabis spending 2018-2024
- Premium Statistic Colorado's medical cannabis spending 2018-2024
- Basic Statistic Washington D.C.'s medical cannabis spending 2018-2024
Related statistics
10
- Premium Statistic Daiichi Sankyo's net income FY 2012-2021
- Premium Statistic Daiichi Sankyo's total assets FY 2012-2021
- Premium Statistic Daiichi Sankyo's total employees FY 2012-2021
- Premium Statistic Fuji Pharma's sales distribution FY 2022, by therapeutic category
- Premium Statistic Fuji Pharma's R&D costs FY 2013-2022
- Premium Statistic Fuji Pharma's total assets FY 2013-2022
- Basic Statistic Fuji Pharma's net sales FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's number of employees FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's total assets FY 2013-2022
- Premium Statistic Takeda Pharmaceutical's net income FY 2013-2022
Further related statistics
10
- Pfizer's ad spending 2008-2022
- Medicinal market growth worldwide including rebates 2009-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
Further Content: You might find this interesting as well
Statistics
- Pfizer's ad spending 2008-2022
- Medicinal market growth worldwide including rebates 2009-2018
- AstraZeneca's revenue from top product Pulmicort 2006-2022
- CVS Health's total assets 2005-2022
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Annual revenue of Sinopharm 2010-2022
- Revenue of Sinopharm 2011-2022, by category
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Celgene's revenue and net income 2006-2018
MHLW (Japan). (December 23, 2022). Production value of hair remedies in Japan in 2021, by item (in billion Japanese yen) [Graph]. In Statista. Retrieved December 07, 2023, from https://www.statista.com/statistics/821069/japan-hair-remedies-production-value-by-item/
MHLW (Japan). "Production value of hair remedies in Japan in 2021, by item (in billion Japanese yen)." Chart. December 23, 2022. Statista. Accessed December 07, 2023. https://www.statista.com/statistics/821069/japan-hair-remedies-production-value-by-item/
MHLW (Japan). (2022). Production value of hair remedies in Japan in 2021, by item (in billion Japanese yen). Statista. Statista Inc.. Accessed: December 07, 2023. https://www.statista.com/statistics/821069/japan-hair-remedies-production-value-by-item/
MHLW (Japan). "Production Value of Hair Remedies in Japan in 2021, by Item (in Billion Japanese Yen)." Statista, Statista Inc., 23 Dec 2022, https://www.statista.com/statistics/821069/japan-hair-remedies-production-value-by-item/
MHLW (Japan), Production value of hair remedies in Japan in 2021, by item (in billion Japanese yen) Statista, https://www.statista.com/statistics/821069/japan-hair-remedies-production-value-by-item/ (last visited December 07, 2023)
Production value of hair remedies in Japan in 2021, by item (in billion Japanese yen) [Graph], MHLW (Japan), December 23, 2022. [Online]. Available: https://www.statista.com/statistics/821069/japan-hair-remedies-production-value-by-item/